• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒相关肝细胞癌肝切除术后的病毒学和生化变化及预后

Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma.

作者信息

Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Higaki I, Takemura S, Yamamoto T, Nishiguchi S, Kinoshita H

机构信息

Second Department of Surgery, Osaka City University Medical School, Osaka, Japan.

出版信息

Dig Surg. 2001;18(1):26-33. doi: 10.1159/000050093.

DOI:10.1159/000050093
PMID:11244256
Abstract

BACKGROUND/AIMS: During the natural course of hepatitis B virus (HBV) infection, clearance of HB e antigen (HBeAg) and HB surface antigen (HBsAg) occurs with remission of liver disease. We investigated the effects of postoperative changes in virologic and biochemical parameters on the prognosis after liver resection for HBV-related hepatocellular carcinoma (HCC).

METHODS

We investigated the relationship between postoperative changes in virologic and biochemical parameters and the incidence of intrahepatic recurrence and the outcome during a 3-year period following surgery in 30 HCC patients with HBsAg.

RESULTS

The incidence of intrahepatic recurrence of HCC was significantly higher in patients with acute postoperative exacerbation of hepatitis (p = 0.0084), a sustained high serum concentration of HBV DNA (> or = 5.0 mEq/ml, p = 0.001), and sustained expression of HBsAg after surgery (p = 0.0421). A high serum concentration of HBV DNA was significantly associated with a shorter survival time (p = 0.0447) and the cause of death was recurrence of HCC.

CONCLUSION

Patients with acute postoperative exacerbation of hepatitis, sustained HBsAg expression, and sustained high serum concentrations of HBV DNA after surgery may require more intensive postoperative monitoring for HCC recurrence.

摘要

背景/目的:在乙型肝炎病毒(HBV)感染的自然病程中,随着肝病的缓解,HBe抗原(HBeAg)和HB表面抗原(HBsAg)会清除。我们研究了病毒学和生化参数的术后变化对HBV相关肝细胞癌(HCC)肝切除术后预后的影响。

方法

我们研究了30例HBsAg阳性的HCC患者术后病毒学和生化参数变化与肝内复发发生率及术后3年结局之间的关系。

结果

术后肝炎急性加重的患者(p = 0.0084)、术后血清HBV DNA持续高浓度(≥5.0 mEq/ml,p = 0.001)以及术后持续表达HBsAg的患者(p = 0.0421),HCC肝内复发的发生率显著更高。血清HBV DNA高浓度与较短的生存时间显著相关(p = 0.0447),死亡原因是HCC复发。

结论

术后肝炎急性加重、术后持续HBsAg表达以及术后血清HBV DNA持续高浓度的患者可能需要更密切的术后监测以观察HCC复发情况。

相似文献

1
Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌肝切除术后的病毒学和生化变化及预后
Dig Surg. 2001;18(1):26-33. doi: 10.1159/000050093.
2
Prognosis in liver transplantation recipients after hepatitis B virus recurrence.乙型肝炎病毒复发后肝移植受者的预后
Hepatogastroenterology. 2014 Oct;61(135):2047-51.
3
High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads.在乙肝病毒载量较低的患者中,高水平的乙肝表面抗原与肝细胞癌患者较差的生存率和早期复发相关。
Ann Surg Oncol. 2015 Mar;22(3):843-50. doi: 10.1245/s10434-014-4043-5. Epub 2014 Oct 1.
4
Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.乙型肝炎病毒相关性肝移植:适应证减少及趋势变化
World J Gastroenterol. 2015 Jul 14;21(26):8140-7. doi: 10.3748/wjg.v21.i26.8140.
5
HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.乙肝病毒脱氧核糖核酸和乙肝表面抗原水平作为乙肝相关肝细胞癌根治性切除术后早期和晚期复发的风险预测指标
Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12.
6
Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.非B非C型肝细胞癌患者的术后结局:对有乙型肝炎感染史患者的亚组分析
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1034-40. doi: 10.1245/s10434-015-4845-0. Epub 2015 Sep 8.
7
Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.乙型肝炎包膜抗原阴性预测乙型肝炎病毒相关肝细胞癌消融治疗后肝内复发。
J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.
8
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌治疗期间的乙型肝炎病毒感染管理
World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249.
9
Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.乙型肝炎病毒相关肝细胞癌患者的肝移植:病毒特征对临床结果的影响。
Ann Surg Oncol. 2013 Oct;20(11):3582-90. doi: 10.1245/s10434-013-3023-5. Epub 2013 Jun 13.
10
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.肝细胞癌与肝移植后乙型肝炎病毒复发风险增加相关。
Gastroenterology. 2008 Jun;134(7):1890-9; quiz 2155. doi: 10.1053/j.gastro.2008.02.064. Epub 2008 Mar 4.

引用本文的文献

1
Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report.乙型肝炎相关性非肝硬化肝细胞癌术后抗病毒联合治疗后的临床治愈及肝纤维化逆转:一例报告
World J Clin Cases. 2021 Jan 26;9(3):714-721. doi: 10.12998/wjcc.v9.i3.714.
2
Two Nomograms to Select Hepatocellular Carcinoma Patients with Macroscopic Vascular Invasion for Hepatic Resection.用于选择伴有肉眼可见血管侵犯的肝细胞癌患者进行肝切除的两个列线图
J Cancer. 2018 Sep 7;9(18):3287-3294. doi: 10.7150/jca.25899. eCollection 2018.
3
The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis.
抗病毒治疗对乙型肝炎病毒相关肝细胞癌患者根治性切除术后的影响:一项系统评价和荟萃分析。
Onco Targets Ther. 2017 Nov 10;10:5363-5375. doi: 10.2147/OTT.S150281. eCollection 2017.
4
Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection.乙型肝炎病毒前-S区缺失可预测根治性切除术后肝细胞癌的复发。
Medicine (Baltimore). 2017 Oct;96(43):e8311. doi: 10.1097/MD.0000000000008311.
5
Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL.乙肝病毒DNA水平<500拷贝/毫升的乙肝相关肝细胞癌患者术后乙肝病毒再激活
Onco Targets Ther. 2016 Jul 25;9:4593-603. doi: 10.2147/OTT.S104300. eCollection 2016.
6
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌治疗期间的乙型肝炎病毒感染管理
World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249.
7
Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study.术后辅助动脉化疗栓塞术可提高乙型肝炎病毒相关肝细胞癌患者的生存率:一项回顾性对照研究。
Ir J Med Sci. 2015 Dec;184(4):753-9. doi: 10.1007/s11845-014-1164-6. Epub 2014 Jun 28.
8
Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus.与肝炎病毒相关的肝细胞癌根治性切除术后的辅助治疗
Liver Cancer. 2013 Jan;2(1):40-6. doi: 10.1159/000346214.
9
High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection.高乙肝病毒载量预测小肝细胞癌根治性切除术后复发。
J Gastrointest Surg. 2010 Jul;14(7):1111-20. doi: 10.1007/s11605-010-1211-1. Epub 2010 Apr 27.
10
Prognostic effects of causative virus in hepatocellular carcinoma according to the Japan integrated staging (JIS) score.根据日本综合分期(JIS)评分,致病病毒在肝细胞癌中的预后影响。
J Gastroenterol. 2005 Oct;40(10):972-9. doi: 10.1007/s00535-005-1681-1.